HBW Advisory Services LLC Invests $61,000 in The Clorox Company (NYSE:CLX)

HBW Advisory Services LLC purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 375 shares of the company’s stock, valued at approximately $61,000.

Several other hedge funds also recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its position in shares of Clorox by 1,525.7% during the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after buying an additional 61,576 shares during the period. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after acquiring an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its stake in Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after purchasing an additional 18,687 shares during the period. Advisors Asset Management Inc. lifted its position in shares of Clorox by 257.5% during the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC purchased a new stake in shares of Clorox during the first quarter valued at $1,025,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of NYSE CLX opened at $161.57 on Friday. The firm has a market cap of $20.07 billion, a PE ratio of 83.72, a PEG ratio of 3.31 and a beta of 0.41. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The firm has a fifty day moving average of $154.91 and a 200 day moving average of $144.43. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. As a group, research analysts predict that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.02%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Wall Street Analysts Forecast Growth

CLX has been the subject of a number of research analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Wells Fargo & Company cut their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, DA Davidson reiterated a “neutral” rating and issued a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $146.13.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.51% of the stock is currently owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.